Lawyer profile
Billy Wu
Latham & Watkins LLP
- Firm
- Latham & Watkins LLP
- Practice
- healthcare and life sciences, intellectual property, licensing and intellectual property
- Office
- Bay Area
- Active in the record
- 2022 to 2024
Deal experience
Deal types
Jurisdictions
Deals
8 announced deals in the record Latham & Watkins Advises Seres Therapeutics in VOWST Asset Purchase Agreement With Nestlé Health Science 7 Aug 2024
Latham & Watkins Advises Coherus BioSciences in Divestment of Ophthalmology Franchise to Sandoz 22 Jan 2024
Latham & Watkins Advises BridgeBio Pharma in US$1.25 Billion Cross-Border Funding 22 Jan 2024
Latham & Watkins Advises Cerevel Therapeutics in Acquisition by AbbVie 7 Dec 2023
Latham & Watkins Advises Ascendis Pharma A/S in Its Royalty Funding Agreement With Royalty Pharma 7 Sept 2023
Latham & Watkins Represents Purigen Biosystems in Its Acquisition by Bionano Genomics 2 Dec 2022
Latham & Watkins Advises Skinbetter Science in Acquisition by L’Oréal 18 Oct 2022
Latham & Watkins Advises CooperCompanies in Acquisition of Cook Medical’s Reproductive Health Business 8 Feb 2022
Deal alerts PRO
Get an email when Billy Wu is named on a newly announced deal.
Alerts come as one daily email at most.
Analytics
Based on announced deals in DealDatabaseLoading analytics…
Complete deal history
Is this you?
Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.
Claim this profile